Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEFLUNOMIDE Cause Intervertebral disc degeneration? 138 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 138 reports of Intervertebral disc degeneration have been filed in association with LEFLUNOMIDE (Leflunomide). This represents 0.2% of all adverse event reports for LEFLUNOMIDE.

138
Reports of Intervertebral disc degeneration with LEFLUNOMIDE
0.2%
of all LEFLUNOMIDE reports
0
Deaths
25
Hospitalizations

How Dangerous Is Intervertebral disc degeneration From LEFLUNOMIDE?

Of the 138 reports, 25 (18.1%) required hospitalization, and 1 (0.7%) were considered life-threatening.

Is Intervertebral disc degeneration Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEFLUNOMIDE. However, 138 reports have been filed with the FAERS database.

What Other Side Effects Does LEFLUNOMIDE Cause?

Drug ineffective (31,396) Rheumatoid arthritis (20,886) Pain (15,594) Drug intolerance (14,142) Joint swelling (13,026) Fatigue (11,959) Arthralgia (11,880) Rash (11,239) Contraindicated product administered (11,206) Abdominal discomfort (10,333)

What Other Drugs Cause Intervertebral disc degeneration?

ADALIMUMAB (873) ALENDRONATE (339) ETANERCEPT (311) METHOTREXATE (308) EMTRICITABINE\TENOFOVIR DISOPROXIL (210) PREGABALIN (204) PREDNISONE (202) RITUXIMAB (200) OXYCODONE (184) SODIUM OXYBATE (178)

Which LEFLUNOMIDE Alternatives Have Lower Intervertebral disc degeneration Risk?

LEFLUNOMIDE vs LEMBOREXANT LEFLUNOMIDE vs LENACAPAVIR LEFLUNOMIDE vs LENALIDOMIDE LEFLUNOMIDE vs LENIOLISIB LEFLUNOMIDE vs LENOGRASTIM

Related Pages

LEFLUNOMIDE Full Profile All Intervertebral disc degeneration Reports All Drugs Causing Intervertebral disc degeneration LEFLUNOMIDE Demographics